IGF-1 LR3 (Insulin-like Growth Factor 1 Long R3) is a synthetic, modified version of IGF-1, a naturally occurring hormone similar in structure to insulin. IGF-1 LR3 is engineered to have an extended half-life and enhanced potency compared to natural IGF-1, making it a popular research peptide for muscle growth, recovery, and metabolic studies.
Mechanism of Action:
Binding to IGF-1 Receptors:
IGF-1 LR3 binds to IGF-1 receptors on cells, triggering intracellular signaling cascades.
This activates pathways like the PI3K-AKT and MAPK pathways, which are crucial for cell growth, survival, and proliferation.
Increased Protein Synthesis:
Stimulates muscle cells to synthesize proteins, leading to growth and repair.
This makes it particularly interesting for applications in muscle wasting or injury recovery research.
Enhanced Glucose Uptake:
Promotes glucose uptake into cells, reducing blood glucose levels and improving cellular energy availability.
Inhibition of Apoptosis:
Prevents programmed cell death in muscle and other tissues, contributing to tissue maintenance.
Prolonged Activity:
The modification to create LR3 involves replacing the arginine at position 3 and removing the IGF-binding protein-binding region.
These changes extend its half-life (up to 20-30 hours) and reduce its affinity for IGF-binding proteins, increasing bioavailability.
Common Applications in Research:
Muscle Growth and Recovery: IGF-1 LR3 is studied for its anabolic effects on muscle tissue.
Tissue Repair: It aids in the repair of various tissues, including cartilage, tendons, and ligaments.
Anti-Aging Studies: Research explores its role in promoting cell regeneration and reducing signs of aging.
Glucose Metabolism: Studies investigate its potential for regulating blood sugar levels in diabetes research.






